CLASS III Device recall · Reported 30 Dec 2015 · FDA Enforcement Report

DrugCheck Waived 12 Panel Cup w/Adult recalled by Ameditech

Ameditech is recalling DrugCheck Waived 12 Panel Cup w/Adult, distributed nationwide in the US. The recall was initiated on 16 Nov 2015 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codes143235 144216 151591 153132 153489
Quantity recalled1,907 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0492-2016
FDA event ID
72651
Recalling firm
Ameditech, San Diego, CA
Classification
Class III
Status
Terminated
Recall initiated
16 Nov 2015
FDA classified
24 Dec 2015
Reported
30 Dec 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

16 Nov 2015Recall initiated by company
24 Dec 2015Classified by FDA+38 days
30 Dec 2015Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.

Product as listed by the FDA

DrugCheck Waived 12 Panel Cup w/Adult, Item No. DCC-81205-5

Where it was distributed

Nationwide Distribution.

Nationwide

Questions about this recall

Is DrugCheck Waived 12 Panel Cup w/Adult recalled?

Yes. Ameditech recalled DrugCheck Waived 12 Panel Cup w/Adult on 16 Nov 2015. The recall is Class III and its status is Terminated. Recall number Z-0492-2016.

Why was it recalled?

Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.

Which lots are affected?

143235 144216 151591 153132 153489

Where was it sold?

Nationwide Distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Ameditech

All 109

Other Other Medical Devices recalls

All 13,771